International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report) was the target of a large decrease in short interest in the month of September. As of September 15th, there was short interest totaling 48 shares, a decrease of 94.1% from the August 31st total of 808 shares. Based on an average daily trading volume, of 124,095 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are short sold.
International Stem Cell Price Performance
International Stem Cell stock remained flat at $0.35 during mid-day trading on Friday. The company’s stock had a trading volume of 11 shares, compared to its average volume of 56,796. International Stem Cell has a 12-month low of $0.12 and a 12-month high of $0.54. The company has a fifty day simple moving average of $0.35 and a 200-day simple moving average of $0.23. The stock has a market cap of $2.77 million and a price-to-earnings ratio of -4.32.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The biotechnology company reported ($0.01) EPS for the quarter. The firm had revenue of $2.67 million during the quarter.
About International Stem Cell
International Stem Cell Corporation is a biotechnology company focused on developing human stem cell-based products and therapies. Its research has centered on proprietary parthenogenetic human stem cells, which are derived from unfertilized human oocytes and are intended to provide a potentially useful source of cells for regenerative medicine.
The company has pursued applications in tissue engineering and cell therapy, including programs involving corneal tissue and other specialized cell types.
See Also
- Five stocks we like better than International Stem Cell
- 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
- SoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
